Mathieson and Smedley-backed Respiri still a disappointment

After forecasting $6 million to $8 million in revenues, the quixotic biotech posted a mere $461,000.

Related Keywords

Melbourne ,Victoria ,Australia ,Simon Pitard ,Nicholas Smedley ,Alan Kohler ,Bruce Mathieson , ,